Condensed Consolidated Statements of Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues
Revenues	$ 92,761	$ 68,778
Expenses:
Cost of product sales	1,265	931
Research and development	46,493	48,388
Selling, general and administrative	59,364	47,867
Royalty	127	7
Total operating expenses	107,249	97,193
Loss from operations	(14,488)	(28,415)
Interest income	4,031	3,378
Interest expense	(24,506)	(27,396)
Foreign currency losses, net	(51)	(229)
Loss before income taxes	(35,014)	(52,662)
Income tax expense	365	671
Net loss	(35,379)	(53,333)
Foreign currency translation adjustment	(253)	59
Unrealized (loss) gain on available for sale investments	(313)	500
Net comprehensive loss	$ (35,945)	$ (52,774)
Basic net loss per common share (in usd per share)	$ (0.17)	$ (0.28)
Diluted net loss per common share (in usd per share)	$ (0.17)	$ (0.28)
Weighted average shares outstanding, basic (in shares)	206,064	188,509
Weighted average shares outstanding, diluted (in shares)	206,064	188,509